Miriam Roncal Redin, Diana Gómez Barroso, Laura Herrera, Javier Gómez-Castellá, Zaida Herrador
{"title":"Estimation of tuberculosis mortality burden in Spain: a review of the major data sources.","authors":"Miriam Roncal Redin, Diana Gómez Barroso, Laura Herrera, Javier Gómez-Castellá, Zaida Herrador","doi":"10.1183/23120541.00636-2024","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>In Spain, notifications of cases of tuberculosis (TB) are registered through the National Epidemiological Surveillance Network (RENAVE). The Minimum Basic Data Set (CMBD) provides information on hospital discharge and the National Statistics Institute (INE) draws on medical death certificates. This study aimed to describe TB mortality in Spain and to compare estimates across data sources, as well as with EU/EEA countries.</p><p><strong>Material and methods: </strong>A retrospective study of TB data between 2008 and 2021 was performed. Mortality rates (MRs) were calculated for the three databases as well as case fatality rates (CFRs) for TB location and HIV status using RENAVE data. Time trends were calculated and the mean MR and annual mean percentage change for Spain were compared with EU/EEA countries.</p><p><strong>Results: </strong>Between 2008 and 2021, 4127 TB deaths were reported to RENAVE, 3877 to INE and 4775 to CMBD. The MR was 0.62 per 100 000 inhabitants for RENAVE, 0.59 for INE and 0.72 for CMBD. A statistically significant downward annual trend was observed. Highest MRs across all databases were found in men and in those over 80 years old. CFR was higher for meningeal TB and for HIV patients with a risk ratio of 2.02 (95% CI 1.82-2.2; p<0.05).</p><p><strong>Conclusion: </strong>Although the TB MR in Spain has followed a downward annual trend, it is necessary to continue improving prevention, diagnosis and treatment. This will require comprehensive measurement, better knowledge and better use of all information to complement surveillance systems.</p>","PeriodicalId":11739,"journal":{"name":"ERJ Open Research","volume":"11 2","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11873880/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ERJ Open Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/23120541.00636-2024","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: In Spain, notifications of cases of tuberculosis (TB) are registered through the National Epidemiological Surveillance Network (RENAVE). The Minimum Basic Data Set (CMBD) provides information on hospital discharge and the National Statistics Institute (INE) draws on medical death certificates. This study aimed to describe TB mortality in Spain and to compare estimates across data sources, as well as with EU/EEA countries.
Material and methods: A retrospective study of TB data between 2008 and 2021 was performed. Mortality rates (MRs) were calculated for the three databases as well as case fatality rates (CFRs) for TB location and HIV status using RENAVE data. Time trends were calculated and the mean MR and annual mean percentage change for Spain were compared with EU/EEA countries.
Results: Between 2008 and 2021, 4127 TB deaths were reported to RENAVE, 3877 to INE and 4775 to CMBD. The MR was 0.62 per 100 000 inhabitants for RENAVE, 0.59 for INE and 0.72 for CMBD. A statistically significant downward annual trend was observed. Highest MRs across all databases were found in men and in those over 80 years old. CFR was higher for meningeal TB and for HIV patients with a risk ratio of 2.02 (95% CI 1.82-2.2; p<0.05).
Conclusion: Although the TB MR in Spain has followed a downward annual trend, it is necessary to continue improving prevention, diagnosis and treatment. This will require comprehensive measurement, better knowledge and better use of all information to complement surveillance systems.
在西班牙,结核病病例的通报是通过国家流行病学监测网(RENAVE)登记的。最低基本数据集(CMBD)提供出院信息,国家统计局(INE)利用医疗死亡证明。本研究旨在描述西班牙的结核病死亡率,并比较不同数据来源以及欧盟/欧洲经济区国家的估计数据。材料和方法:对2008年至2021年间的结核病数据进行了回顾性研究。使用RENAVE数据计算了三个数据库的死亡率(MRs)以及结核病地点和艾滋病毒状态的病死率(CFRs)。计算了时间趋势,并将西班牙与欧盟/欧洲经济区国家的平均MR和年平均百分比变化进行了比较。结果:2008年至2021年间,RENAVE报告了4127例结核病死亡,INE报告了3877例,CMBD报告了4775例。RENAVE的死亡率为每10万居民0.62人,INE为0.59人,CMBD为0.72人。年下降趋势在统计上有显著意义。在所有数据库中,男性和80岁以上的人的mr值最高。脑膜炎结核和HIV患者的CFR较高,风险比为2.02 (95% CI 1.82-2.2;结论:尽管西班牙结核病发病率呈逐年下降趋势,但仍有必要继续加强预防、诊断和治疗。这将需要全面的衡量、更好的知识和更好地利用所有信息来补充监测系统。
期刊介绍:
ERJ Open Research is a fully open access original research journal, published online by the European Respiratory Society. The journal aims to publish high-quality work in all fields of respiratory science and medicine, covering basic science, clinical translational science and clinical medicine. The journal was created to help fulfil the ERS objective to disseminate scientific and educational material to its members and to the medical community, but also to provide researchers with an affordable open access specialty journal in which to publish their work.